Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan's National Health Insurance Research Database.
BACKGROUND:High-cost orphan drugs are becoming increasingly available to treat rare diseases that affect a relatively small population. Little attention has been given to the prevalence of rare diseases and their health-related economic burden in Taiwan. OBJECTIVES:This study examined the national t...
Main Authors: | Jason C Hsu, Huai-Chueh Wu, Wen-Chia Feng, Chih-Ho Chou, Edward Chia-Cheng Lai, Christine Y Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6150502?pdf=render |
Similar Items
-
The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database
by: Hung YN, et al.
Published: (2016-08-01) -
Taiwan Controlled Substances Database
by: Yung-Wen Huang, et al.
Published: (2022-12-01) -
Disease burden from foodborne illnesses in Taiwan, 2012–2015
by: Ying-Ho Lai, et al.
Published: (2020-09-01) -
Taiwan’s National Health Insurance Research Database: past and future
by: Hsieh CY, et al.
Published: (2019-05-01) -
Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
by: Shu-Chen Wei, et al.
Published: (2017-07-01)